TRIMETHOBENZAMIDE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Trimethobenzamide Hydrochloride, and what generic alternatives are available?
Trimethobenzamide Hydrochloride is a drug marketed by Avet Lifesciences, Lupin, Sun Pharm Industries, Am Regent, Hospira, Smith And Nephew, Solopak, and Watson Labs. and is included in eleven NDAs.
The generic ingredient in TRIMETHOBENZAMIDE HYDROCHLORIDE is trimethobenzamide hydrochloride. There are six drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the trimethobenzamide hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Trimethobenzamide Hydrochloride
A generic version of TRIMETHOBENZAMIDE HYDROCHLORIDE was approved as trimethobenzamide hydrochloride by LUPIN on August 20th, 2003.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TRIMETHOBENZAMIDE HYDROCHLORIDE?
- What are the global sales for TRIMETHOBENZAMIDE HYDROCHLORIDE?
- What is Average Wholesale Price for TRIMETHOBENZAMIDE HYDROCHLORIDE?
Summary for TRIMETHOBENZAMIDE HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 8 |
| NDAs: | 11 |
| Finished Product Suppliers / Packagers: | 6 |
| Raw Ingredient (Bulk) Api Vendors: | 68 |
| Clinical Trials: | 4 |
| Patent Applications: | 405 |
| DailyMed Link: | TRIMETHOBENZAMIDE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for TRIMETHOBENZAMIDE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Kyowa Kirin | Phase 2 |
| Indiana University | Phase 2 |
| Pfizer | Phase 1 |
Pharmacology for TRIMETHOBENZAMIDE HYDROCHLORIDE
| Drug Class | Antiemetic |
| Physiological Effect | Emesis Suppression |
Anatomical Therapeutic Chemical (ATC) Classes for TRIMETHOBENZAMIDE HYDROCHLORIDE
US Patents and Regulatory Information for TRIMETHOBENZAMIDE HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Avet Lifesciences | TRIMETHOBENZAMIDE HYDROCHLORIDE | trimethobenzamide hydrochloride | CAPSULE;ORAL | 205950-001 | Nov 21, 2023 | AB | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Smith And Nephew | TRIMETHOBENZAMIDE HYDROCHLORIDE | trimethobenzamide hydrochloride | INJECTABLE;INJECTION | 089043-001 | Apr 4, 1986 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Am Regent | TRIMETHOBENZAMIDE HYDROCHLORIDE | trimethobenzamide hydrochloride | INJECTABLE;INJECTION | 091330-001 | Mar 8, 2011 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
